A recent study showed that inhibition of sphingosine kinase-1 (SK1) resulted in decreased Tregs trafficking to the tumor and consequently enhanced response to ICI in the murine model of various cancers including melanoma [54]. This evidence concerns the gene SPHK1 and melanoma.